A detailed history of Pfw Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pfw Advisors LLC holds 1,200 shares of ABBV stock, worth $219,516. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,200
Previous 1,394 13.92%
Holding current value
$219,516
Previous $254 Million 18.92%
% of portfolio
0.07%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $30,029 - $35,067
-194 Reduced 13.92%
1,200 $206 Million
Q1 2024

Apr 11, 2024

BUY
$159.82 - $182.1 $6,232 - $7,101
39 Added 2.88%
1,394 $254 Million
Q4 2023

Jan 22, 2024

BUY
$137.6 - $154.97 $186,448 - $209,984
1,355 New
1,355 $210 Million
Q3 2019

Oct 09, 2024

BUY
$62.98 - $75.72 $1,196 - $1,438
19 Added 1.58%
1,219 $241 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $323B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pfw Advisors LLC Portfolio

Follow Pfw Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfw Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfw Advisors LLC with notifications on news.